scholarly journals A novel keratin 13 variant in a four-generation family with white sponge nevus

2017 ◽  
Vol 5 (9) ◽  
pp. 1503-1509 ◽  
Author(s):  
Stephanie B. de Haseth ◽  
Egbert Bakker ◽  
Maarten H. Vermeer ◽  
Hakima el Idrissi ◽  
Tjalling Bosse ◽  
...  
Author(s):  
Hercílio Martelli ◽  
Samantha Mourão Pereira ◽  
Thábata Martins Rocha ◽  
Paulo Luis Antônio Nogueira dos Santos ◽  
Alfredo Maurício Batista de Paula ◽  
...  

2001 ◽  
Vol 80 (3) ◽  
pp. 919-923 ◽  
Author(s):  
A. Terrinoni ◽  
E.L. Rugg ◽  
E.B. Lane ◽  
G. Melino ◽  
D.H. Felix ◽  
...  

Author(s):  
Yasuyuki Shibuya ◽  
Jianming Zhang ◽  
Satoshi Yokoo ◽  
Masahiro Umeda ◽  
Takahide Komori

2017 ◽  
Vol 47 (2) ◽  
pp. 152-157 ◽  
Author(s):  
Maria Westin ◽  
Elham Rekabdar ◽  
Lena Blomstrand ◽  
Per Klintberg ◽  
Mats Jontell ◽  
...  

Meta Gene ◽  
2014 ◽  
Vol 2 ◽  
pp. 374-383 ◽  
Author(s):  
Wenping Cai ◽  
Zhenghu Chen ◽  
Beizhan Jiang ◽  
Fang Yu ◽  
Ping Xu ◽  
...  

1995 ◽  
Vol 11 (4) ◽  
pp. 453-455 ◽  
Author(s):  
Gabriela Richard ◽  
Vincenzo De Laurenzi ◽  
Biagio Didona ◽  
Sherri J. Bale ◽  
John G. Compton

Author(s):  
Wenping Cai ◽  
Beizhan Jiang ◽  
Fang Yu ◽  
Jianhua Yang ◽  
Zhenghu Chen ◽  
...  

White sponge nevus (WSN) in the oral mucosa is a rare autosomal dominant genetic disease. The involved mucosa is white or greyish, thickened, folded and spongy. The genes associated with WSN include mutant cytokeratin keratin 4 (KRT4) and keratin 13 (KRT13). In recent years, new cases of WSN and associated mutations have been reported. Here, we summarise the recent progress in our understanding of WSN, including clinical reports, genetics, animal models, treatment, pathogenic mechanisms and future directions. Gene-based diagnosis and gene therapy for WSN may become available in the near future and could provide a reference and instruction for treating other KRT-associated diseases.


2020 ◽  
Vol 468 (1-2) ◽  
pp. 146-153
Author(s):  
Laura Simonson ◽  
Samantha Vold ◽  
Colton Mowers ◽  
Randall J. Massey ◽  
Irene M. Ong ◽  
...  

Genes ◽  
2021 ◽  
Vol 12 (4) ◽  
pp. 512
Author(s):  
Aleksandra Gilis-Januszewska ◽  
Anna Bogusławska ◽  
Kornelia Hasse-Lazar ◽  
Beata Jurecka-Lubieniecka ◽  
Barbara Jarząb ◽  
...  

Multiple neuroendocrine neoplasia type 1 (MEN1) is a rare genetic disorder with an autosomal dominant inheritance, predisposing carriers to benign and malignant tumors. The phenotype of MEN1 syndrome varies between patients in terms of tumor localization, age of onset, and clinical aggressiveness, even between affected members within the same family. We describe a heterogenic phenotype of the MEN1 variant c.781C>T (LRG_509t1), which was previously reported only once in a family with isolated hyperparathyroidism. A heterozygous missense variant in exon 4 of the gene was identified in the sequence of the MEN1 gene, i.e., c.781C>T, leading to the amino acid change p.Leu261Phe in a three-generation family. In the screened family, 5/6 affected members had already developed hyperparathyroidism. In the index patient and two other family members, an aggressive course of pancreatic neuroendocrine tumor (insulinoma and non-functioning neuroendocrine tumors) with dissemination was diagnosed. In the index patient, late diagnosis and slow progression of the disseminated neuroendocrine tumor have been observed (24 years of follow-up). The very rare variant of MEN1, LRG_509t1 c.781C>T /p.Leu261Phe (LRG_509p1), diagnosed within a three-generation family has a heterogenic clinical presentation. Further follow-up of the family members should be carried out to confirm the spectrum and exact time of clinical presentation.


Sign in / Sign up

Export Citation Format

Share Document